James Cavanaugh - Aug 23, 2023 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Role: Director
Signature: /s/ Douglas E. Onsi as attorney-in-fact for James Cavanaugh
Stock symbol: LPTX
Transactions as of: Aug 23, 2023
Transactions value $: $0
Form type: 4
Date filed: 8/25/2023, 04:30 PM
Previous filing: Apr 4, 2023
Next filing: Jan 31, 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LPTX	Stock Option (Right to Buy)	Award	$0	+15K		$0.00	15K	Aug 23, 2023	Common Stock	15K	$2.21	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of November 23, 2023, February 23, 2024, May 23, 2024 and August 23, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company.

Content

The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of November 23, 2023, February 23, 2024, May 23, 2024 and August 23, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company.